Doctors Note Logo

Published on: 8/18/2026

Understanding Late-Onset Adult HPP: Why Mild Childhood Symptoms Go Undetected

Adult-onset hypophosphatasia (HPP) is a rare genetic condition caused by low alkaline phosphatase activity, and it often begins with childhood clues so subtle that they are dismissed, including early loss of baby teeth, delayed walking, frequent stress fractures, or being labeled clumsy or "growing pains" prone. Because these signs fade or fluctuate, many adults are not diagnosed until their 30s, 40s, or later, when recurring metatarsal fractures, thigh pain, chondrocalcinosis, dental loss, or unexplained fatigue and muscle weakness finally prompt testing. Persistently low serum ALP, elevated vitamin B6, and ALPL gene testing are key to confirmation, and misdiagnosis as osteoporosis, fibromyalgia, or osteomalacia is common and can lead to treatments that make bone health worse. There are several important factors, red flags, and testing details to weigh, so see below to understand more before assuming your symptoms are unrelated.

If long-standing bone pain, fractures, or early tooth loss have never been fully explained, a free, instant, online symptom check can help you organize your history, spot patterns worth investigating, and walk into your next appointment ready to ask about alkaline phosphatase testing.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

Understanding Late-Onset Adult Hypophosphatasia (HPP): Why Mild Childhood Symptoms Go Undetected

Hypophosphatasia (HPP) is a rare, inherited disorder caused by mutations in the ALPL gene, which encodes the enzyme tissue-nonspecific alkaline phosphatase (TNSALP). This enzyme plays a key role in bone mineralization and vitamin B6 metabolism. When TNSALP activity is low, minerals like calcium and phosphate can’t deposit properly in bones and teeth, leading to a wide spectrum of symptoms.

Can adults develop Hypophosphatasia later in life?

Yes. While some people experience severe symptoms in the womb or as infants, others have such mild signs in childhood that the condition goes undetected until adolescence or adulthood. These individuals may “outgrow” early hints or simply adapt to them, only to face more noticeable problems later on.


Why do mild childhood symptoms slip under the radar?

  1. Variable presentation

    • HPP symptoms range from life-threatening (perinatal form) to very mild (odontohypophosphatasia, affecting only teeth).
    • Mild bone pain, delayed walking, or early tooth loss can be attributed to clumsiness, growing pains, or routine dental issues.
  2. Non-specific complaints

    • Children with subtle HPP may have occasional aches, fatigue, or small fractures after minor bumps—symptoms that mimic common childhood injuries or sports-related strains.
  3. Inconsistent lab monitoring

    • Routine blood tests in childhood don’t always include alkaline phosphatase (ALP) levels unless there’s a clear bone or liver concern.
    • Low ALP can be overlooked or misinterpreted as lab error.
  4. Diagnostic challenges

    • Healthcare providers may first suspect more common disorders—such as juvenile arthritis, osteoporosis, or fibromyalgia—before considering a rare enzyme deficiency.

Hallmarks of late-onset adult HPP

When mild childhood HPP is not recognized, adults may start to notice:

  • Frequent stress fractures or “pseudofractures.” These small cracks in weight-bearing bones (especially the feet and legs) can occur with minimal trauma.
  • Chronic bone and joint pain. Arthralgia (joint pain), osteoarthritis-like symptoms, or soft tissue calcifications.
  • Muscle weakness or fatigue. Difficulty keeping up with daily activities.
  • Early loss of adult teeth. Loosened or prematurely lost molars without gum disease.
  • Low ALP levels on blood tests. A hallmark but often dismissed if mild.
  • High levels of ALP substrates. Pyridoxal-5-phosphate (PLP, a form of vitamin B6) and inorganic pyrophosphate can accumulate.

How does HPP progress into adulthood?

  • Partial enzyme activity
    Mild ALPL gene mutations allow some TNSALP function. In childhood, residual activity may be enough for near-normal growth and development.
  • Cumulative effects
    Over years, even slight mineralization defects can lead to microdamage in bones. Small cracks become stress fractures; joints develop premature wear and tear.
  • Environmental and lifestyle factors
    Repetitive stress (running, heavy lifting), poor diet, vitamin D insufficiency, or certain medications (like bisphosphonates) can unmask or worsen bone weakness.

Diagnosing adult-onset HPP

A clear pathway helps avoid misdiagnosis:

  1. Clinical history

    • Ask about childhood milestones (walking age, dental history).
    • Note family history of fractures, early tooth loss, or unexplained bone pain.
  2. Physical exam

    • Look for tenderness over long bones, foot deformities, dental abnormalities, and joint swelling or crepitus.
  3. Laboratory tests

    • Serum alkaline phosphatase (ALP): consistently low for age and sex.
    • PLP (vitamin B6): elevated when TNSALP is low.
    • Calcium and phosphate: often normal or slightly high.
  4. Genetic testing

    • Confirms ALPL mutations and helps determine inheritance pattern (autosomal recessive or dominant).
  5. Imaging studies

    • X-rays or MRI to detect pseudofractures, osteopenia, or calcifications in ligaments and cartilage.

Treatment and management strategies

While there is no cure for HPP, tailored approaches can significantly improve quality of life:

• Enzyme replacement therapy
Asfotase alfa (Strensiq®) is FDA-approved for pediatric and adult HPP in many countries. It supplements deficient alkaline phosphatase and improves bone mineralization.

• Pain management
Analgesics, physical therapy, and low-impact exercise (swimming, walking) help maintain mobility and reduce discomfort.

• Fracture care
Specialty orthopedic input for stress-fractures or non-healing bone injuries. Avoid bisphosphonates—they can worsen bone brittleness in HPP.

• Dental interventions
Routine dental follow-up, with special attention to periodontal health and replacement options for early tooth loss.

• Nutritional support
Adequate calcium, vitamin D, and protein intake. Avoid high-phosphate foods if phosphate levels are already elevated.

• Genetic counseling
Discuss inheritance risks for future children and family screening if a mutation is found.


Living well with adult-onset HPP

People with late-onset HPP can lead full lives by:

  • Building a supportive healthcare team: endocrinologist, rheumatologist, dentist, orthopedic surgeon, and physical therapist.
  • Monitoring bone health regularly: bone density scans and blood tests.
  • Adapting activities: focus on low-impact exercise, avoid high-force impacts.
  • Staying informed: connect with patient advocacy groups and reliable medical sources.

When to seek medical advice

Because HPP symptoms overlap with many other conditions, it helps to track and share details with your provider:

  • Duration and location of bone or joint pain
  • Frequency of fractures or unusual healing patterns
  • Timing of tooth loosening or loss
  • Results of any previous ALP tests or vitamin B6 measurements

If you’re uncertain whether your symptoms warrant a deeper look, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather insights before your next appointment.


Key takeaways

  • Mild childhood symptoms of HPP often go undetected until adulthood when cumulative bone damage becomes painful or disabling.
  • Adults can indeed develop or become symptomatic from Hypophosphatasia later in life, thanks to partial enzyme function in early years.
  • Early recognition of low ALP levels and genetic testing can prevent misdiagnosis and guide appropriate treatment.
  • A multidisciplinary approach—combining enzyme replacement, pain management, fracture care, and dental support—offers the best outcomes.
  • Always discuss anything that feels serious or life-threatening with a doctor promptly.

If you suspect HPP or have unexplained bone, muscle, or dental issues, speak with your healthcare provider. Early evaluation and tailored management can help you maintain mobility, reduce pain, and protect your long-term bone health.

(References)

  • * Mornet E. Hypophosphatasia. Best Pract Res Clin Rheumatol. 2008 Mar;22(1):113-27. doi: 10.1016/j.berh.2007.11.003. PMID: 18328985.

  • * Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.

  • * Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Marini JC, Dang Do AN. Osteogenesis Imperfecta. 2000. PMID: 25905334.

  • * Mornet E. Hypophosphatasia. Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. Epub 2017 Sep 20. PMID: 28939177.

  • * Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, Wallon F, Rousseau N, Charle C, Guberto M, Muti C, Simon-Bouy B. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021 Feb;29(2):289-299. doi: 10.1038/s41431-020-00732-6. Epub 2020 Sep 24. PMID: 32973344; PMCID: PMC7868366.

  • * Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.

  • * Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021 Dec 1;10(23). doi: 10.3390/jcm10235676. Epub 2021 Dec 1. PMID: 34884378; PMCID: PMC8658462.

  • * Farman MR, Rehder C, Malli T, Rockman-Greenberg C, Dahir K, Martos-Moreno GÁ, Linglart A, Ozono K, Seefried L, Del Angel G, Webersinke G, Barbazza F, John LK, Delana Mudiyanselage SMA, Högler F, Nading EB, Huggins E, Rush ET, El-Gazzar A, Kishnani PS, Högler W. The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 2024 Jan;178:116947. doi: 10.1016/j.bone.2023.116947. Epub 2023 Oct 26. PMID: 37898381.

  • * Brandi ML, Khan AA, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Roux C. The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance. Osteoporos Int. 2024 Mar;35(3):439-449. doi: 10.1007/s00198-023-06859-8. Epub 2023 Nov 20. PMID: 37982856.

  • * Pascart T, Filippou G, Lioté F, Sirotti S, Jauffret C, Abhishek A. Calcium pyrophosphate deposition disease. Lancet Rheumatol. 2024 Nov;6(11):e791-e804. doi: 10.1016/S2665-9913(24)00122-X. Epub 2024 Jul 29. PMID: 39089298.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.